로열티 파마 PLC
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionJefferies Group LLC
Latest Disclosed Ownership21,500 shares
Latest Disclosed Value $ 863,870
Jefferies Group LLC ownership in RPRX / Royalty Pharma plc

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 21,500 shares of Royalty Pharma plc (US:RPRX) valued at $863,870 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 4,501 shares of Royalty Pharma plc. This represents a change in shares of 377.67% during the quarter. The current value of the position is $1,201,205 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (RPRX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RPRX / Royalty Pharma plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 21,500 16,999 377.67 864 356.61 0.0072
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 34,402 29,901 857 0.0068
2023-09-21 2022-06-30 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 4,501 4,501 189 0.0016
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 4,501 4,501 189 0.0015
2023-09-21 2022-03-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 0 -620 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 0 -620 0
2023-09-21 2021-12-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 620 620 25 0.0001
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 620 620 25 0.0001
2023-09-21 2020-12-31 13F/A-1 ROYALTY PHARMA SHS CL A G7709Q104 0 -59,100 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ROYALTY PHARMA SHS CL A G7709Q104 0 -59,100 0
2020-11-13 2020-09-30 13F ROYALTY PHARMA SHS CL A G7709Q104 59,100 59,100 2,486 0.0275
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 n/a n/a n/a
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A Put 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A ROYALTY PHARMA SHS CLASS A Put 10,000 0 n/a n/a n/a
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A Put 10,000 0 n/a n/a n/a
2023-09-21 2022-03-31 13F/A ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 n/a n/a n/a
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A Put 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A ROYALTY PHARMA SHS CLASS A Put 20,000 0.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A Put 20,000 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A ROYALTY PHARMA SHS CLASS A Put 20,000 723 n/a n/a n/a
2023-09-21 2021-09-30 13F/A ROYALTY PHARMA SHS CLASS A Put 20,000 723 n/a n/a n/a
2021-11-15 2021-09-30 13F ROYALTY PHARMA SHS CLASS A Put 20,000 723 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.